Alisertib demonstrates significant antitumor activity in bevacizumab resistant, patient derived orthotopic models of glioblastoma

Por Kurokawa, C, Geekiyanage, H, Allen, C, Iankov, I, Schroeder, M, Carlson, B, Bakken, K, Sarkaria, J, Ecsedy, JA, D’Assoro, A, Friday, B, Galanis, E
Publicado no J Neurooncol (2016)